Supraventricular tachycardia is a common emergency department (ED) pathology that frequently leads to hospital admission, but this may not be necessary in all cases. Here, we present a supraventricular tachycardia patient who was discharged from the ED after vagal maneuvers. This case demonstrates evidence that judicious emergency physicians can discharge supraventricular tachycardia patients home safely and gives impetus for a data-driven protocol for discharging these patients.
Supraventricular tachycardia is an arrhythmia frequently encountered by emergency physicians and accounts for over 50,000 cases in emergency departments (EDs) in the United States per year . Multiple approaches have been described for the management of patients presenting with supraventricular tachycardia, but most patients are cardioverted with intravenous (IV) drugs or electricity and admitted to the hospital. We present the case of a 66-year-old male patient with supraventricular tachycardia who was discharged from the emergency department following vagal maneuver cardioversion and a short, two-hour observation period in the emergency department. This case illustrates the possibility of discharging patients with supraventricular tachycardia from the emergency department based on risk factors and suggests the possibility of researching a data-driven protocol for discharging these patients similar to those available for other common presentations.
A 66-year-old male with a past medical history of hyperlipidemia, hypertension, and frequent episodes of supraventricular tachycardia presented via ambulance with a chief complaint of tachycardia. The patient was eating lunch at work that day when he started to experience palpitations. Typically, palpitations resolved by taking deep breaths and trying to relax, but, today, this did not resolve his symptoms, so he called an ambulance who did not attempt cardioversion before transport to the ED due to timing. On arrival to the emergency department, the patient’s initial vital signs showed a heart rate in the 180s, but, otherwise, the vital signs were within normal limits. History revealed that the patient complained of dyspnea and anxiety but, otherwise, his review of systems was negative for chest pain, dizziness, cough, and fever. His physical exam was notable for anxiety and regular rhythm tachycardia on auscultation but was otherwise unremarkable. The patient reported that he had a cardiologist and denied any coronary artery disease history. The initial electrocardiogram is shown in Figure 1.
The patient was treated with 1 liter of normal saline and modified vagal maneuvers, as shown in the REVERT trial , which converted him to sinus rhythm without medications (Figure 2). The workup performed included hemogram and electrolytes but no cardiac enzymes. The patient was discharged to follow-up with his cardiologist outpatient in two to three days and had no further complications.
Supraventricular tachycardia is a common condition that tends to affect patients, recur at times, and then spontaneously resolve for long periods before affecting patients again. Many times, these patients are admitted to the hospital where they are simply observed. However, here, we present the case of a patient who was discharged home post-cardioversion after several factors were considered. These factors supporting discharge include no chest pain, no history of coronary artery disease, a long history of supraventricular tachycardia (SVT) followed by a cardiologist, with similar symptoms in the past, and an arrhythmia that resolved in the ED without any cardiac medications or electricity.
The main reason the patient would need to be sent to observation is to rule out cardiac ischemia. As previously mentioned, other than his arrhythmia, the patient was asymptomatic, and a quick assessment of his risk factors determined his disposition. When called, his cardiologist confirmed that the patient had a normal stress test six months ago when he had his first episode of supraventricular tachycardia. This made the diagnosis of acute coronary syndrome in this patient lower on the differential. Additionally, this patient’s post-conversion electrocardiogram was normal, without signs of ischemia.
The next test considered was a troponin, but the implications of this test can be far-reaching and misleading if used incorrectly in SVT. Often, in the ED, troponins are ordered in order to rule out ischemia from a focal coronary source, but the increased troponin in supraventricular tachycardia is usually global, demand, or rate-related ischemia, which resolves upon cardioversion . There is a debate on the usefulness of troponins in supraventricular tachycardia patients because increased troponins and even ST-depression on an electrocardiogram are not always accurate markers of acute coronary syndrome [3-4]. Alternatively, other studies show that patients with supraventricular tachycardia and elevated troponins have increased mortality and morbidity rates, but most of these studied patients had other comorbidities such as coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure , which, if present, would make one think about admission for these patients regardless of the troponin. The consensus on troponin testing for SVT is inconclusive, but the evidence seems to suggest that troponins risk stratify high-risk patients but should not be used in patients who are low risk and likely to be discharged unless one is aware of the implications of a mild elevation in this setting [6-7]. In other words, one should not hinge their entire paroxysmal supraventricular tachycardia patient’s disposition on a troponin as one may in other cases. Troponins should be ordered selectively for high-risk supraventricular tachycardia patients and do not need to be ordered in every case. In this case, the history from the patient's cardiologist made the patient lower risk but a personal cardiologist is seldom available for all patients in the ED.
Currently, there is a push to algorithmizing the practice of emergency medicine, and a one-size-fits-all disposition approach does not work for certain diagnoses like supraventricular tachycardia. The episodic nature of supraventricular tachycardia means that once the patient is cardioverted, there is no further reason to keep the patient in the hospital unless new symptoms occur, indicating a different process. Supraventricular tachycardia usually does not indicate coronary artery disease. Emergency physicians should order troponins only judiciously because ordering them may cause unnecessary admissions and even coronary catheterizations for patients who likely do not have coronary artery disease. Further studies and data collection could create a clinical pathway algorithm for discharging these patients that is similar to those protocols available for other common presentations in the ED.
- Murman DH, McDonald AJ, Pelletier AJ, Camargo CA Jr.: US emergency department visits for supraventricular tachycardia, 1993-2003. Acad Emerg Med. 2008, 6:578-581. 10.1197/j.aem.2007.01.013
- Appelboam A, Reuben A, Mann C, et al.: Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet. 2015, 10005:1747-1753. 10.1016/S0140-6736(15)61485-4
- Yedder NB, Roux JF, Paredes FA: Troponin elevation in supraventricular tachycardia: primary dependence on heart rate. Can J Cardiol. 2011, 27:105-109. 10.1016/j.cjca.2010.12.004
- Bukkapatnam RN, Robinson M, Turnipseed S, Tancredi D, Amsterdam E, Srivatsa UN: Relationship of myocardial ischemia and injury to coronary artery disease in patients with supraventricular tachycardia. Am J Cardiol. 2010, 106: 374-377. 10.1016/j.amjcard.2010.03.035
- Chow G, Hirsch G, Spragg D, Cai J, Cheng A, Ziegelstein R, Marine J: Prognostic significance of cardiac troponin I levels in hospitalized patients presenting with supraventricular tachycardia. Medicine. 2010, 89:141-147. 10.1097/MD.0b013e3181dddb3b
- Mackway-Jones K: Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Emerg Med J. 2010, 27:141-142. 10.1136/emj.20.4.362
- Healey JS: Troponin elevation in patients with supraventricular tachycardia: what does it mean?. Can J Cardiol. 2011, 27:110-111. 10.1016/j.cjca.2010.12.003
Paroxysmal Supraventricular Tachycardia
Ethics Statement and Conflict of Interest Disclosures
Human subjects: Consent was obtained by all participants in this study. AdventHealth Office of Sponsored Programs issued approval 1433614-1. OFFICE OF SPONSORED PROGRAMS LETTER OF INSTITUTIONAL ACKNOWLEDGEMENT
PI: Casey Arnold, MD Project Title: [1433614-1] Paroxysmal Supraventricular Tachycardia APPROVED as of: April 30, 2019
Congratulations! AdventHealth's Office of Sponsored Programs (OSP) has given Institutional Acknowledgement to the Case Study identified above.
If you did not provide the OSP with a final version of your Case Study, please be sure to do so once you receive your publication copy or the final copy that you presented at a conference. In addition, it is the responsibility of the PI to notify the OSP of any Federal Sanction(s), including Debarment and/or Suspension(s).
If you have any questions about research policy and procedures, or if we may assist you in any way, please feel free to contact the OSP.
Please refer to the AdventHealth IRBNet ID# in all communications and documents related to this project.
Office of Sponsored Programs. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Cite this article as:
Arnold C, Martinez Martinez C J (June 11, 2019) Paroxysmal Supraventricular Tachycardia. Cureus 11(6): e4883. doi:10.7759/cureus.4883
Received by Cureus: May 10, 2019
Peer review began: May 16, 2019
Peer review concluded: May 31, 2019
Published: June 11, 2019
© Copyright 2019
Arnold et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.